A Study of the Safety and Immunogenicity of High-Dose Quadrivalent Influenza Vaccine in Subjects Aged 65 Years and Older
Clinical trial NCT02553343 · COMPLETED
Trial details
- NCT number
- NCT02553343
- Sponsor
- Sanofi Pasteur, a Sanofi Company
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-09-01
- Primary completion
- 2016-04-04
- Enrollment
- 792
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.